BioHealth News

Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531

Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531

GAITHERSBURG, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first patient has been dosed…

Read More
Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million

Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million

GAITHERSBURG, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the sale of RSDL® (Reactive Skin Decontamination Lotion) kit to SERB…

Read More
Montgomery County Council Approves Great Seneca Plan: Connecting Life and Science

Montgomery County Council Approves Great Seneca Plan: Connecting Life and Science

ROCKVILLE, Md., July 30, 2024—The Montgomery County Council voted today to approve the Planning Board Draft of the Great Seneca Plan: Connecting Life and Science…

Read More
WBJ: Metro, Montgomery County partner for major North Bethesda development

WBJ: Metro, Montgomery County partner for major North Bethesda development

By Dan Brendel – Staff Reporter, Washington Business Journal -Jul 29, 2024 - Montgomery County and Metro have announced a formal partnership and preliminary…

Read More
Frederick’s Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

Frederick’s Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

FREDERICK, Md., July 29, 2024 /PRNewswire-PRWeb/ -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a…

Read More
TEDCO Invests in Azadi Health

TEDCO Invests in Azadi Health

COLUMBIA, Md., (July 29, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $100,000 Pre-Seed Builder Fund investment in Azadi Health.…

Read More
BioHealth Innovation Celebrates Solaxa Inc.’s Recent TEDCO Investment

BioHealth Innovation Celebrates Solaxa Inc.’s Recent TEDCO Investment

BioHealth Innovation, Inc. (BHI) proudly recognizes the $500,000 investment from TEDCO in Solaxa Inc., a Bethesda-based biopharmaceutical company. Led by Founder & CEO Christian…

Read More
BioHealth Capital Region Maintains #3 Ranking: Insights with GEN’s Alex Philippidis on BioTalk

BioHealth Capital Region Maintains #3 Ranking: Insights with GEN’s Alex Philippidis on BioTalk

In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Alex Philippidis, Senior Business Editor at Genetic Engineering…

Read More
BioBuzz: Growth of Early-Stage Resident Companies Marks the Third Anniversary of Johnson & Johnson Innovation – JLABS @ Washington, DC

BioBuzz: Growth of Early-Stage Resident Companies Marks the Third Anniversary of Johnson & Johnson Innovation – JLABS @ Washington, DC

In celebration of the three-year anniversary of JLABS @ Washington, DC (JLABS DC), it’s great timing to highlight recent accomplishments and milestones reached by…

Read More
George Mason researchers lead breakthrough study to find functional cure for HIV

George Mason researchers lead breakthrough study to find functional cure for HIV

July 25, 2024 / By Laura Powers: Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study,…

Read More
Washington DC’s 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support

Washington DC’s 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support

WASHINGTON, July 25, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases,…

Read More
Maryland Global Consulting Program – Unlocking Your Business’s Global Potential

Maryland Global Consulting Program – Unlocking Your Business’s Global Potential

Ready to take your business to the global stage? Join the Maryland Global Consulting Program through the Robert H. Smith School of Business Center…

Read More
BioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters for 2024

BioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters for 2024

The BioHealth Capital Region (Maryland, Virginia, and Washington, D.C.) has successfully retained its position as the #3 biopharma cluster in the U.S. for 2024.…

Read More
MedCityNews: How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance

MedCityNews: How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance

RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD. MiRecule, winner in the…

Read More
Mirecule Wins MedCity INVEST 2024 Competition

Mirecule Wins MedCity INVEST 2024 Competition

Chicago, May 2024 — miRecule, a cutting-edge startup focused on developing antibody RNA conjugate therapeutics, clinched the top spot at the prestigious MedCity INVEST…

Read More